Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Tendoactive, Eccentric Training, and the Combination of Both as a Treatment of Achilles Tendinopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients suffering from a gradually evolving painful condition in the Achilles tendon located at the midportion for at least 3 months (Diagnosis based on clinical examination showing a painful thickening of the Achilles tendon located at a level of 2 to 6cm above the tendon insertion, and confirmed by ultrasonography: local thickening of the tendon, irregular tendon structure with hypoechoic areas and irregular fiber orientation).~* Men and non-pregnant women aged 18-70 years~* Be informed of the nature of the study and provide written informed consent.~Exclusion Criteria:~* Clinical suspicion of insertional disorders (pain at the site of the insertion of the Achilles tendon on the calcaneum)~* Clinical suspicion of an Achilles tendon rupture (Thompson test abnormal and palpable gap)~* Clinical suspicion of plantar flexor tenosynovitis (posteromedial pain when the toes are plantar flexed against resistance)~* Clinical suspicion of n.suralis pathology (sensitive disorder in the area of the sural nerve)~* Clinical suspicion of peroneal subluxation~* Suspicion of internal disorders: spondylarthropathy, gout, hyperlipidemia, Rheumatoid Arthritis and sarcoidosis.~* Condition that prevents the patients from executing an active exercise programme~* Patient has already performed eccentric exercises, according to the schedule of Alfredson et al (12 weeks)~* Patient has already received an injection of PRP for this injury~* Patient does not wish, for whatever reason, to undergo one of the two treatments~* Known presence of a pregnancy~* Condition of the Achilles tendon caused by medications (arising in relation to moment of intake), such as quinolones and statins

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Tendoactive (Type: EXPERIMENTAL): Tendoactive dosage: 3 capsules per day
- Eccentric training (Type: ACTIVE_COMPARATOR): Protocol published by Alfredson et al 1998 (Am J Sports Med 1998 26: 360)
- Tendoactive and eccentric training (Type: ACTIVE_COMPARATOR): Tendoactive dosage: 3 capsules per day. Eccentric training: protocol described by Alfredson et al 1998 (Am J Sports Med 1998 26: 360)

Based on this trial design, predict the completion outcome and termination type (if applicable).